Key result
Idiopathic venous thromboembolism was associated with a 6.89% incidence of subsequent cancer diagnosis within 2 years of the first episode.
Why the study?
What is the incidence of subsequent cancer diagnosis in patients with idiopathic venous thromboembolism?
Cohort (n=28,243)
Yes
What is the incidence of subsequent cancer diagnosis in patients with idiopathic venous thromboembolism?
Patients with idiopathic VTE have a 6.89% incidence of subsequent cancer diagnosis within 2 years, suggesting that extensive screening for occult cancer may be warranted in this population.
May support targeted cancer screening after idiopathic VTE; leaves open whether routine protocols improve outcomes.
BACKGROUND: Several studies have indicated an association between venous thromboembolism (VTE) and a subsequent diagnosis of cancer in Western countries. However, information is scant on subsequent cancer incidence after idiopathic VTE events in Asian people. Through a nationwide cohort study, we evaluated the cancer prevalence of VTE and new cancer incidence in patients after the first episode of idiopathic VTE. METHODS: To conduct a nationwide population cohort study on VTE, we retrieved data from the Taiwan National Health Insurance Database from 1998 to 2008, including a 2-year follow-up period extending to the end of 2010. The occurrence of cancer in the cohort was also determined by accessing the Registry for Catastrophic Illness Patient Database. RESULTS: A total of 45,242 patients had the newly diagnosed VTE from 1998 to 2008. The incidence of VTE increased with age. Among 28,243 idiopathic VTE patients, 1944 patients (6.89%) had a subsequent cancer diagnosis within 2 years of the first idiopathic VTE episode. The three most common newly diagnosed cancers after idiopathic VTE were lung cancer, liver cancer and colorectal cancer (18.3%, 12.3% and 10.9%, respectively). Male sex and advanced age are independent risk factors of having an underlying malignant disorder among patients diagnosed with idiopathic VTE. CONCLUSION: Patients with symptomatic VTE without an identifiable risk factor have a 6.89% incidence of subsequent cancer diagnosis in Taiwan. An extensive screening for an occult cancer in an idiopathic VTE patient may be warranted.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2014) conducted a cohort in Idiopathic venous thromboembolism (n=28,243). Idiopathic venous thromboembolism was evaluated on Subsequent cancer diagnosis within 2 years. Idiopathic venous thromboembolism was associated with a 6.89% incidence of subsequent cancer diagnosis within 2 years of the first episode.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: